November 10, 2016
The Ministry of Health, Labor and Welfare (MHLW) is in the final stages of arranging a 50% price slash for Ono Pharmaceutical’s immuno-oncology med Opdivo (nivolumab) under an emergency pricing measure it has set out to rein in drug spending...read more